A bayesian approach to evaluating regional treatment effect in a multiregional trial

Journal of Biopharmaceutical Statistics

Volumn 19, Issue 5, 2009, Pages 900-915

  Chen, Yi Hau ^a   Wu, Ya Chi ^b   Wang, Mey ^b  

^a INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^b Center for Drug Evaluation   (Taiwan)

Author keywords

Empirical Bayes; Global clinical studies; Power; Sample size allocation

Indexed keywords

PLACEBO;

ANALYSIS OF VARIANCE; ARTICLE; ASIAN; BAYES THEOREM; EMPIRICISM; ETHNIC DIFFERENCE; HUMAN; MEASUREMENT ERROR; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; SAMPLE SIZE; SIMULATION; SURVIVAL; TREATMENT RESPONSE;

ANTIHYPERTENSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BAYES THEOREM; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; MULTICENTER STUDIES AS TOPIC; ODDS RATIO; RESIDENCE CHARACTERISTICS; SAMPLE SIZE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 75149119685     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903105471     Document Type: Article

References (10)

1. Efron, B. (1996). Empirical Bayes methods for combining likelihoods. J. Am. Stat. Assoc. 91:538-550. (Pubitemid 126412819)
2. International Conference on Harmonization. (1998a). Tripartite Guideline E5 on Ethnic Factors in the Acceptability of Foreign Clinical Data. http://www.ich.org/LOB/ media/MEDIA481.pdf
3. International Conference on Harmonization. (1998b). Tripartite Guideline E9 on Statistical Principles for Clinical Trials. http://www.emea.europa.eu/ pdfs/human/ ich/036396en.pdf.
4. International Conference on Harmonization. (2006). Q&A for the ICH Guideline E5 on Ethnic Factors in the Acceptability of Foreign Clinical Data. http://www.ich.org/ LOB/media/MEDIA1194.pdf
5. Kahn, R. S., Schulz, S. C., Palazov, V. D., Reyes, E. B., Brecher, M., Svensson, O., Andersson, H. M., Meulien, D. (2007). Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: A randomized, double-blind, placebo-controlled study. J. Clin. Psychiatry 68:832-842.
6. Kawai, N., Chuang-Stein, C., Komiyama, O., Ii, Y. (2008). An approach to rationalize partitioning sample size into individual regions in a multiregional trial. Drug Information J. 42:139-147.
7. SAS Institute Inc. (2006). SAS Online Doc 9.1.3. Cary, NC: SAS Institute Inc.
8. Simon, R. (1999). Bayesian design and analysis of active control clinical trials. Biometrics 55:484-487.
9. Snapinn, S. (2008). Multinational (global) trial. In: D'Agostino, R., Sullivan, L., Massaro, J., eds. Encyclopedia of Clinical Trials. Vol.3. New York: Wiley, pp. 170-173.
10. Zar, J. (1999). Biostatistical Analysis. 4th ed. Englewood Cliffs, NJ: Prentice Hall.